CERN Corporation, with a valuation of $12 million, is raising funds on StartEngine. The company is developing an effective and non-drug therapeutic treatment for fungal and bacterial vaginosis. The Cern Device uses microbicidal light to mitigate pathogens causing fungal and bacterial vaginosis to promote a healthy microbiome without using drugs. The device is the size of a tampon and can be used at home as and when needed. CERN Corporation has received utility and design patents and is in the pre-revenue and testing stages of development. Gregg A. Klang founded CERN Corporation in February 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for commercial device development, clinical trials, FDA clearance, and marketing.